Suppr超能文献

多囊蛋白-2 的活性受转录共激活因子与 PDZ 结合基序和紧密连接蛋白相关的 PALS1 控制。

Polycystin-2 activity is controlled by transcriptional coactivator with PDZ binding motif and PALS1-associated tight junction protein.

机构信息

Department of Internal Medicine D, Molecular Nephrology, University Clinics of Münster, University of Münster, D-48149 Münster.

出版信息

J Biol Chem. 2010 Oct 29;285(44):33584-8. doi: 10.1074/jbc.C110.146381. Epub 2010 Sep 10.

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent monogenic cause of kidney failure, characterized by the development of renal cysts. ADPKD is caused by mutations of the polycystin-1 (PC1) or polycystin-2 (PC2) genes. PC2 encodes a Ca(2+)-permeable cation channel, and its dysfunction has been implicated in cyst development. The transcriptional coactivator with PDZ binding motif (TAZ) is required for the integrity of renal cilia. Its absence results in the development of renal cysts in a knock-out mouse model. TAZ directly interacts with PC2, and it has been suggested that another yet unidentified PDZ domain protein may be involved in the TAZ/PC2 interaction. Here we describe a novel interaction of TAZ with the multi-PDZ-containing PALS1-associated tight junction protein (PATJ). TAZ interacts with both the N-terminal PDZ domains 1-3 and the C-terminal PDZ domains 8-10 of PATJ, suggesting two distinct TAZ binding domains. We also show that the C terminus of PC2 strongly interacts with PDZ domains 8-10 and to a weaker extent with PDZ domains 1-3 of PATJ. Finally, we demonstrate that both TAZ and PATJ impair PC2 channel activity when co-expressed with PC2 in oocytes of Xenopus laevis. These results implicate TAZ and PATJ as novel regulatory elements of the PC2 channel and might thus be involved in ADPKD pathology.

摘要

常染色体显性多囊肾病 (ADPKD) 是最常见的肾脏衰竭的单基因病因,其特征为肾囊肿的发展。ADPKD 是由多囊蛋白-1 (PC1) 或多囊蛋白-2 (PC2) 基因突变引起的。PC2 编码钙通透性阳离子通道,其功能障碍与囊肿的发展有关。具有 PDZ 结合基序的转录共激活因子 (TAZ) 是肾脏纤毛完整性所必需的。在敲除小鼠模型中,其缺失会导致肾脏囊肿的发展。TAZ 与 PC2 直接相互作用,并且有人提出另一种尚未鉴定的 PDZ 结构域蛋白可能参与 TAZ/PC2 相互作用。在这里,我们描述了 TAZ 与多 PDZ 包含的 PALS1 相关紧密连接蛋白 (PATJ) 的新相互作用。TAZ 与 PATJ 的 N 端 PDZ 结构域 1-3 和 C 端 PDZ 结构域 8-10 相互作用,表明存在两个不同的 TAZ 结合结构域。我们还表明,PC2 的 C 末端与 PATJ 的 PDZ 结构域 8-10 强烈相互作用,并以较弱的程度与 PDZ 结构域 1-3 相互作用。最后,我们证明当在非洲爪蟾卵母细胞中与 PC2 共表达时,TAZ 和 PATJ 均会损害 PC2 通道的活性。这些结果表明 TAZ 和 PATJ 是 PC2 通道的新型调节因子,因此可能参与 ADPKD 病理学。

相似文献

1
4
Polycystin 2 interacts with type I inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling.
J Biol Chem. 2005 Dec 16;280(50):41298-306. doi: 10.1074/jbc.M510082200. Epub 2005 Oct 13.
5
Polycystin-2 interacts with troponin I, an angiogenesis inhibitor.
Biochemistry. 2003 Jan 21;42(2):450-7. doi: 10.1021/bi0267792.
6
Similar and distinct properties of MUPP1 and Patj, two homologous PDZ domain-containing tight-junction proteins.
Mol Cell Biol. 2009 May;29(9):2372-89. doi: 10.1128/MCB.01505-08. Epub 2009 Mar 2.
7
The carboxyl terminus of zona occludens-3 binds and recruits a mammalian homologue of discs lost to tight junctions.
J Biol Chem. 2002 Jul 26;277(30):27501-9. doi: 10.1074/jbc.M201177200. Epub 2002 May 20.
8
Polycystin-2 induces a conformational change in polycystin-1.
Biochemistry. 2013 Aug 6;52(31):5280-7. doi: 10.1021/bi400233e. Epub 2013 Jul 24.
9
A polycystin-2 (TRPP2) dimerization domain essential for the function of heteromeric polycystin complexes.
EMBO J. 2010 Apr 7;29(7):1176-91. doi: 10.1038/emboj.2010.18. Epub 2010 Feb 18.
10
Expression of the polycystin-1 C-terminal cytoplasmic tail increases Cl channel activity in Xenopus oocytes.
Kidney Int. 2005 Aug;68(2):632-41. doi: 10.1111/j.1523-1755.2005.00441.x.

引用本文的文献

1
DLG1 functions upstream of SDCCAG3 and IFT20 to control ciliary targeting of polycystin-2.
EMBO Rep. 2024 Jul;25(7):3040-3063. doi: 10.1038/s44319-024-00170-1. Epub 2024 Jun 7.
2
DLG1 functions upstream of SDCCAG3 and IFT20 to control ciliary targeting of polycystin-2.
bioRxiv. 2024 Mar 14:2023.11.10.566524. doi: 10.1101/2023.11.10.566524.
3
PATJ inhibits histone deacetylase 7 to control tight junction formation and cell polarity.
Cell Mol Life Sci. 2023 Oct 25;80(11):333. doi: 10.1007/s00018-023-04994-3.
4
Yap controls notochord formation and neural tube patterning by integrating mechanotransduction with and expression.
Sci Adv. 2023 Jun 16;9(24):eadf6927. doi: 10.1126/sciadv.adf6927. Epub 2023 Jun 14.
5
Research Progress on PATJ and Underlying Mechanisms Associated with Functional Outcomes After Stroke.
Neuropsychiatr Dis Treat. 2021 Aug 26;17:2811-2818. doi: 10.2147/NDT.S310764. eCollection 2021.
7
Intracellular APOL1 Risk Variants Cause Cytotoxicity Accompanied by Energy Depletion.
J Am Soc Nephrol. 2017 Nov;28(11):3227-3238. doi: 10.1681/ASN.2016111220. Epub 2017 Jul 10.
8
The Vac14-interaction network is linked to regulators of the endolysosomal and autophagic pathway.
Mol Cell Proteomics. 2014 Jun;13(6):1397-411. doi: 10.1074/mcp.M113.034108. Epub 2014 Feb 27.
9
Regulation of the Hippo pathway and implications for anticancer drug development.
Trends Pharmacol Sci. 2013 Oct;34(10):581-9. doi: 10.1016/j.tips.2013.08.006. Epub 2013 Sep 16.
10
TAZ suppresses NFAT5 activity through tyrosine phosphorylation.
Mol Cell Biol. 2012 Dec;32(24):4925-32. doi: 10.1128/MCB.00392-12. Epub 2012 Oct 8.

本文引用的文献

1
The Hippo pathway regulates Wnt/beta-catenin signaling.
Dev Cell. 2010 Apr 20;18(4):579-91. doi: 10.1016/j.devcel.2010.03.007.
2
Nephrocystin-1 and nephrocystin-4 are required for epithelial morphogenesis and associate with PALS1/PATJ and Par6.
Hum Mol Genet. 2009 Dec 15;18(24):4711-23. doi: 10.1093/hmg/ddp434. Epub 2009 Sep 14.
3
Disrupting specific PDZ domain-mediated interactions for therapeutic benefit.
Br J Pharmacol. 2009 Sep;158(2):483-5. doi: 10.1111/j.1476-5381.2009.00359.x.
4
The Hippo tumor-suppressor pathway regulates apical-domain size in parallel to tissue growth.
J Cell Sci. 2009 Jul 15;122(Pt 14):2351-9. doi: 10.1242/jcs.046482. Epub 2009 Jun 16.
5
Apical lumen formation in renal epithelia.
J Am Soc Nephrol. 2009 Jul;20(7):1444-52. doi: 10.1681/ASN.2008090949. Epub 2009 Jun 4.
6
Homophilic and heterophilic polycystin 1 interactions regulate E-cadherin recruitment and junction assembly in MDCK cells.
J Cell Sci. 2009 May 1;122(Pt 9):1410-7. doi: 10.1242/jcs.045021. Epub 2009 Apr 7.
7
TEADs mediate nuclear retention of TAZ to promote oncogenic transformation.
J Biol Chem. 2009 May 22;284(21):14347-58. doi: 10.1074/jbc.M901568200. Epub 2009 Mar 26.
9
The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
Curr Opin Cell Biol. 2008 Dec;20(6):638-46. doi: 10.1016/j.ceb.2008.10.001. Epub 2008 Nov 18.
10
Polycystic kidney disease.
Annu Rev Med. 2009;60:321-37. doi: 10.1146/annurev.med.60.101707.125712.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验